-
Diabetes in Central Asia: Why Primary Clinics Need Blood Glucose Monitoring
Diabetes is rising fast in Central Asia. Learn why primary clinics should adopt blood glucose monitoring, HbA1c tests, and immunoassay analyzers.
19-09-2025 -
New Clinical Consensus Released in China: HbA1c Point-of-Care Testing Gains Further Support
China has released new expert consensus on HbA1c POCT, emphasizing its role in diabetes screening at primary care. Learn how your clinic in Malaysia or Thailand can benefit using rapid 15-min fluorescent immunoassay systems.
07-07-2025 -
Exhibition Preview: Medlab Middle East 2025
22-01-2025




